当前位置: X-MOL 学术East Asian Economic Review › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
The Health Impact of, and access to, New Drugs in Korea
East Asian Economic Review Pub Date : 2020-06-30 , DOI: 10.11644/kiep.eaer.2020.24.2.374
Frank R. Lichtenberg

We perform an econometric assessment of the role that pharmaceutical innovation— the introduction and use of new drugs—has played in improving the health of Koreans, by investigating whether diseases for which more new drugs were launched had larger subsequent increases in longevity and smaller subsequent increases in hospitalization. Drugs launched during 1993-2012 are estimated to have increased mean age at death from all diseases by 1.71 years between 1995 and 2015 and 1.09 years between 2005 and 2015. We also estimate that new drugs increased the five-year relative survival rate from all cancers combined by 23.2 percentage points—78.5% of the total increase—between 1993-1995 and 2011-2015, and that new drugs launched during 2008-2010 reduced the number of hospital days in 2017 by 13.0 million. If the drugs launched during 2003-2012 had had no effect on other medical expenditure in 2015, the cost per life-year gained would not have exceeded 6332 USD. Therefore, even if we ignore the effect of new drugs on hospital utilization, the drugs launched during 2003-2012 were very cost–effective, overall. When reduced hospital utilization is accounted for, the evidence indicates that, in the long run, pharmaceutical innovation was cost-saving as well as life-year saving.

中文翻译:

韩国新药对健康的影响和获取

我们通过调查是否发明了更多新药的疾病后继寿命增加较大,后继增加率较小而对药物创新(新药的引入和使用)在改善韩国人健康中所起的作用进行了计量经济学评估在住院中。据估计,在1993年至2012年期间投放的药物使所有疾病的平均死亡年龄增加了1995年至2015年的1.71年和2005年至2015年的1.09年。我们还估计,新药可提高所有癌症的五年相对存活率。从1993年至1995年至2011年至2015年之间的总和增加了23.2个百分点,占总增长的78.5%,而在2008年至2010年期间推出的新药使2017年的住院天数减少了1300万。如果在2003年至2012年期间投放的药物对2015年的其他医疗支出没有影响,则每生命年增加的成本不会超过6332美元。因此,即使我们忽略了新药对医院利用率的影响,总体而言,2003-2012年间推出的新药还是具有很高的成本效益的。有证据表明,考虑到医院利用率的降低,从长远来看,药物创新既可以节省成本,又可以节省生命周期。
更新日期:2020-06-30
down
wechat
bug